 | • レポートコード：GIR201106057 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、腫瘍溶解性ウイルスの世界市場を調査対象にし、腫瘍溶解性ウイルスの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（HSVベース腫瘍溶解性ウイルス、アデノウイルスベース腫瘍溶解性ウイルス、ワクシニアウイルスベース腫瘍溶解性ウイルス、水疱性口内炎ウイルスベース腫瘍溶解性ウイルス、ニューカッスル病ウイルスベース腫瘍溶解性ウイルス）、用途別分析（製薬、医療、商業）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Merck、Neotropix、Roche、Otsuka Pharmaceutical Co、Latima、Pfizer、SillaJen、Genelux、Cold Genesys、Shanghai Sunway Biotech、Takara Bio、Theravir ・メーカー別販売量、売上、市場シェア ・腫瘍溶解性ウイルスの地域別市場分析 ・腫瘍溶解性ウイルスの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・腫瘍溶解性ウイルスのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・腫瘍溶解性ウイルスのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・腫瘍溶解性ウイルスの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・腫瘍溶解性ウイルスの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・腫瘍溶解性ウイルスの種類別市場規模2015-2020：HSVベース腫瘍溶解性ウイルス、アデノウイルスベース腫瘍溶解性ウイルス、ワクシニアウイルスベース腫瘍溶解性ウイルス、水疱性口内炎ウイルスベース腫瘍溶解性ウイルス、ニューカッスル病ウイルスベース腫瘍溶解性ウイルス ・腫瘍溶解性ウイルスの用途別市場規模2015-2020：製薬、医療、商業 ・腫瘍溶解性ウイルスの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Oncolytic Virus market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Oncolytic Virus market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Oncolytic Virus market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oncolytic Virus market has been segmented into
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
By Application, Oncolytic Virus has been segmented into:
Pharmaceutical
Health Care
Commerical
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncolytic Virus market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncolytic Virus markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncolytic Virus market.
The report offers in-depth assessment of the growth and other aspects of the Oncolytic Virus market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Oncolytic Virus Market Share Analysis
Oncolytic Virus competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oncolytic Virus sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncolytic Virus sales, revenue and market share for each player covered in this report.
The major players covered in Oncolytic Virus are:
Merck
Neotropix
Roche
Otsuka Pharmaceutical Co
Latima
Pfizer
SillaJen
Genelux
Cold Genesys
Shanghai Sunway Biotech
Takara Bio
Theravir
Among other players domestic and global, Oncolytic Virus market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncolytic Virus product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncolytic Virus, with price, sales, revenue and global market share of Oncolytic Virus in 2018 and 2019.
Chapter 3, the Oncolytic Virus competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncolytic Virus breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Oncolytic Virus market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Oncolytic Virus sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Oncolytic Virus Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncolytic Virus Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 HSV-based Oncolytic Viruses
1.2.3 Adenoviruses-based Oncolytic Viruses
1.2.4 Vaccinia Virus-based Oncolytic Viruses
1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
1.2.6 Newcastle Disease Virus-based Oncolytic Viruses
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncolytic Virus Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical
1.3.3 Health Care
1.3.4 Commerical
1.4 Overview of Global Oncolytic Virus Market
1.4.1 Global Oncolytic Virus Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Neotropix
2.2.1 Neotropix Details
2.2.2 Neotropix Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Neotropix SWOT Analysis
2.2.4 Neotropix Product and Services
2.2.5 Neotropix Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Roche SWOT Analysis
2.3.4 Roche Product and Services
2.3.5 Roche Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Otsuka Pharmaceutical Co
2.4.1 Otsuka Pharmaceutical Co Details
2.4.2 Otsuka Pharmaceutical Co Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Otsuka Pharmaceutical Co SWOT Analysis
2.4.4 Otsuka Pharmaceutical Co Product and Services
2.4.5 Otsuka Pharmaceutical Co Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Latima
2.5.1 Latima Details
2.5.2 Latima Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Latima SWOT Analysis
2.5.4 Latima Product and Services
2.5.5 Latima Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 SillaJen
2.7.1 SillaJen Details
2.7.2 SillaJen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 SillaJen SWOT Analysis
2.7.4 SillaJen Product and Services
2.7.5 SillaJen Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genelux
2.8.1 Genelux Details
2.8.2 Genelux Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genelux SWOT Analysis
2.8.4 Genelux Product and Services
2.8.5 Genelux Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cold Genesys
2.9.1 Cold Genesys Details
2.9.2 Cold Genesys Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Cold Genesys SWOT Analysis
2.9.4 Cold Genesys Product and Services
2.9.5 Cold Genesys Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Shanghai Sunway Biotech
2.10.1 Shanghai Sunway Biotech Details
2.10.2 Shanghai Sunway Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Shanghai Sunway Biotech SWOT Analysis
2.10.4 Shanghai Sunway Biotech Product and Services
2.10.5 Shanghai Sunway Biotech Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Takara Bio
2.11.1 Takara Bio Details
2.11.2 Takara Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Takara Bio SWOT Analysis
2.11.4 Takara Bio Product and Services
2.11.5 Takara Bio Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Theravir
2.12.1 Theravir Details
2.12.2 Theravir Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Theravir SWOT Analysis
2.12.4 Theravir Product and Services
2.12.5 Theravir Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Oncolytic Virus Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Oncolytic Virus Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Oncolytic Virus Manufacturer Market Share in 2019
3.3.2 Top 6 Oncolytic Virus Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Oncolytic Virus Sales, Revenue and Market Share by Regions
4.1.1 Global Oncolytic Virus Sales and Market Share by Regions (2015-2020)
4.1.2 Global Oncolytic Virus Revenue and Market Share by Regions (2015-2020)
4.2 North America Oncolytic Virus Sales and Growth Rate (2015-2020)
4.3 Europe Oncolytic Virus Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Oncolytic Virus Sales and Growth Rate (2015-2020)
4.5 South America Oncolytic Virus Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Oncolytic Virus Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Oncolytic Virus Sales, Revenue and Market Share by Country
5.1.1 North America Oncolytic Virus Sales and Market Share by Country (2015-2020)
5.1.2 North America Oncolytic Virus Revenue and Market Share by Country (2015-2020)
5.2 United States Oncolytic Virus Sales and Growth Rate (2015-2020)
5.3 Canada Oncolytic Virus Sales and Growth Rate (2015-2020)
5.4 Mexico Oncolytic Virus Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Oncolytic Virus Sales, Revenue and Market Share by Country
6.1.1 Europe Oncolytic Virus Sales and Market Share by Country (2015-2020)
6.1.2 Europe Oncolytic Virus Revenue and Market Share by Country (2015-2020)
6.2 Germany Oncolytic Virus Sales and Growth Rate (2015-2020)
6.3 UK Oncolytic Virus Sales and Growth Rate (2015-2020)
6.4 France Oncolytic Virus Sales and Growth Rate (2015-2020)
6.5 Russia Oncolytic Virus Sales and Growth Rate (2015-2020)
6.6 Italy Oncolytic Virus Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Oncolytic Virus Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Oncolytic Virus Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Oncolytic Virus Revenue and Market Share by Regions (2015-2020)
7.2 China Oncolytic Virus Sales and Growth Rate (2015-2020)
7.3 Japan Oncolytic Virus Sales and Growth Rate (2015-2020)
7.4 Korea Oncolytic Virus Sales and Growth Rate (2015-2020)
7.5 India Oncolytic Virus Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Oncolytic Virus Sales and Growth Rate (2015-2020)
7.7 Australia Oncolytic Virus Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Oncolytic Virus Sales, Revenue and Market Share by Country
8.1.1 South America Oncolytic Virus Sales and Market Share by Country (2015-2020)
8.1.2 South America Oncolytic Virus Revenue and Market Share by Country (2015-2020)
8.2 Brazil Oncolytic Virus Sales and Growth Rate (2015-2020)
8.3 Argentina Oncolytic Virus Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Oncolytic Virus Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Oncolytic Virus Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Oncolytic Virus Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Oncolytic Virus Sales and Growth Rate (2015-2020)
9.3 Turkey Oncolytic Virus Sales and Growth Rate (2015-2020)
9.4 Egypt Oncolytic Virus Sales and Growth Rate (2015-2020)
9.5 South Africa Oncolytic Virus Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Oncolytic Virus Sales and Market Share by Type (2015-2020)
10.2 Global Oncolytic Virus Revenue and Market Share by Type (2015-2020)
10.3 Global Oncolytic Virus Price by Type (2015-2020)
11 Global Oncolytic Virus Market Segment by Application
11.1 Global Oncolytic Virus Sales Market Share by Application (2015-2020)
11.2 Global Oncolytic Virus Revenue Market Share by Application (2015-2020)
11.3 Global Oncolytic Virus Price by Application (2015-2020)
12 Market Forecast
12.1 Global Oncolytic Virus Sales, Revenue and Growth Rate (2021-2025)
12.2 Oncolytic Virus Market Forecast by Regions (2021-2025)
12.2.1 North America Oncolytic Virus Market Forecast (2021-2025)
12.2.2 Europe Oncolytic Virus Market Forecast (2021-2025)
12.2.3 Asia-Pacific Oncolytic Virus Market Forecast (2021-2025)
12.2.4 South America Oncolytic Virus Market Forecast (2021-2025)
12.2.5 Middle East & Africa Oncolytic Virus Market Forecast (2021-2025)
12.3 Oncolytic Virus Market Forecast by Type (2021-2025)
12.3.1 Global Oncolytic Virus Sales Forecast by Type (2021-2025)
12.3.2 Global Oncolytic Virus Market Share Forecast by Type (2021-2025)
12.4 Oncolytic Virus Market Forecast by Application (2021-2025)
12.4.1 Global Oncolytic Virus Sales Forecast by Application (2021-2025)
12.4.2 Global Oncolytic Virus Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Oncolytic Virus Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oncolytic Virus by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oncolytic Virus Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Oncolytic Virus Major Business
Table 9. Merck Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 10. Merck SWOT Analysis
Table 11. Merck Oncolytic Virus Product and Services
Table 12. Merck Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Neotropix Basic Information, Manufacturing Base and Competitors
Table 14. Neotropix Oncolytic Virus Major Business
Table 15. Neotropix Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 16. Neotropix SWOT Analysis
Table 17. Neotropix Oncolytic Virus Product and Services
Table 18. Neotropix Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Roche Basic Information, Manufacturing Base and Competitors
Table 20. Roche Oncolytic Virus Major Business
Table 21. Roche Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 22. Roche SWOT Analysis
Table 23. Roche Oncolytic Virus Product and Services
Table 24. Roche Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Otsuka Pharmaceutical Co Basic Information, Manufacturing Base and Competitors
Table 26. Otsuka Pharmaceutical Co Oncolytic Virus Major Business
Table 27. Otsuka Pharmaceutical Co Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 28. Otsuka Pharmaceutical Co SWOT Analysis
Table 29. Otsuka Pharmaceutical Co Oncolytic Virus Product and Services
Table 30. Otsuka Pharmaceutical Co Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Latima Basic Information, Manufacturing Base and Competitors
Table 32. Latima Oncolytic Virus Major Business
Table 33. Latima Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 34. Latima SWOT Analysis
Table 35. Latima Oncolytic Virus Product and Services
Table 36. Latima Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer Oncolytic Virus Major Business
Table 39. Pfizer Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer Oncolytic Virus Product and Services
Table 42. Pfizer Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. SillaJen Basic Information, Manufacturing Base and Competitors
Table 44. SillaJen Oncolytic Virus Major Business
Table 45. SillaJen Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 46. SillaJen SWOT Analysis
Table 47. SillaJen Oncolytic Virus Product and Services
Table 48. SillaJen Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Genelux Basic Information, Manufacturing Base and Competitors
Table 50. Genelux Oncolytic Virus Major Business
Table 51. Genelux Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 52. Genelux SWOT Analysis
Table 53. Genelux Oncolytic Virus Product and Services
Table 54. Genelux Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Cold Genesys Basic Information, Manufacturing Base and Competitors
Table 56. Cold Genesys Oncolytic Virus Major Business
Table 57. Cold Genesys Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 58. Cold Genesys SWOT Analysis
Table 59. Cold Genesys Oncolytic Virus Product and Services
Table 60. Cold Genesys Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Shanghai Sunway Biotech Basic Information, Manufacturing Base and Competitors
Table 62. Shanghai Sunway Biotech Oncolytic Virus Major Business
Table 63. Shanghai Sunway Biotech Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 64. Shanghai Sunway Biotech SWOT Analysis
Table 65. Shanghai Sunway Biotech Oncolytic Virus Product and Services
Table 66. Shanghai Sunway Biotech Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Takara Bio Basic Information, Manufacturing Base and Competitors
Table 68. Takara Bio Oncolytic Virus Major Business
Table 69. Takara Bio Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 70. Takara Bio SWOT Analysis
Table 71. Takara Bio Oncolytic Virus Product and Services
Table 72. Takara Bio Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Theravir Basic Information, Manufacturing Base and Competitors
Table 74. Theravir Oncolytic Virus Major Business
Table 75. Theravir Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 76. Theravir SWOT Analysis
Table 77. Theravir Oncolytic Virus Product and Services
Table 78. Theravir Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Oncolytic Virus Sales by Manufacturer (2018-2019) (K MT)
Table 80. Global Oncolytic Virus Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Oncolytic Virus Sales by Regions (2015-2020) (K MT)
Table 82. Global Oncolytic Virus Sales Market Share by Regions (2015-2020)
Table 83. Global Oncolytic Virus Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Oncolytic Virus Sales by Countries (2015-2020) (K MT)
Table 85. North America Oncolytic Virus Sales Market Share by Countries (2015-2020)
Table 86. North America Oncolytic Virus Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Oncolytic Virus Revenue Market Share by Countries (2015-2020)
Table 88. Europe Oncolytic Virus Sales by Countries (2015-2020) (K MT)
Table 89. Europe Oncolytic Virus Sales Market Share by Countries (2015-2020)
Table 90. Europe Oncolytic Virus Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Oncolytic Virus Sales by Regions (2015-2020) (K MT)
Table 92. Asia-Pacific Oncolytic Virus Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Oncolytic Virus Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Oncolytic Virus Sales by Countries (2015-2020) (K MT)
Table 95. South America Oncolytic Virus Sales Market Share by Countries (2015-2020)
Table 96. South America Oncolytic Virus Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Oncolytic Virus Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Oncolytic Virus Sales by Countries (2015-2020) (K MT)
Table 99. Middle East & Africa Oncolytic Virus Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Oncolytic Virus Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Oncolytic Virus Revenue Market Share by Countries (2015-2020)
Table 102. Global Oncolytic Virus Sales by Type (2015-2020) (K MT)
Table 103. Global Oncolytic Virus Sales Share by Type (2015-2020)
Table 104. Global Oncolytic Virus Revenue by Type (2015-2020) (USD Million)
Table 105. Global Oncolytic Virus Revenue Share by Type (2015-2020)
Table 106. Global Oncolytic Virus Sales by Application (2015-2020) (K MT)
Table 107. Global Oncolytic Virus Sales Share by Application (2015-2020)
Table 108. Global Oncolytic Virus Sales Forecast by Regions (2021-2025) (K MT)
Table 109. Global Oncolytic Virus Market Share Forecast by Regions (2021-2025)
Table 110. Global Oncolytic Virus Sales Forecast by Type (2021-2025) (K MT)
Table 111. Global Oncolytic Virus Market Share Forecast by Type (2021-2025)
Table 112. Global Oncolytic Virus Sales Forecast by Application (2021-2025)
Table 113. Global Oncolytic Virus Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Oncolytic Virus Picture
Figure 2. Global Sales Market Share of Oncolytic Virus by Type in 2019
Figure 3. HSV-based Oncolytic Viruses Picture
Figure 4. Adenoviruses-based Oncolytic Viruses Picture
Figure 5. Vaccinia Virus-based Oncolytic Viruses Picture
Figure 6. Vesicular Stomatitis Virus-based Oncolytic Viruses Picture
Figure 7. Newcastle Disease Virus-based Oncolytic Viruses Picture
Figure 8. Oncolytic Virus Sales Market Share by Application in 2018
Figure 9. Pharmaceutical Picture
Figure 10. Health Care Picture
Figure 11. Commerical Picture
Figure 12. Global Oncolytic Virus Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Oncolytic Virus Sales Market Share by Manufacturer in 2019
Figure 33. Global Oncolytic Virus Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Oncolytic Virus Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Oncolytic Virus Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 38. Global Oncolytic Virus Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Oncolytic Virus Revenue Market Share by Regions (2015-2020)
Figure 40. Global Oncolytic Virus Revenue Market Share by Regions in 2018
Figure 41. North America Oncolytic Virus Sales and Growth Rate (2015-2020)
Figure 42. Europe Oncolytic Virus Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Oncolytic Virus Sales and Growth Rate (2015-2020)
Figure 44. South America Oncolytic Virus Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Oncolytic Virus Sales and Growth Rate (2015-2020)
Figure 46. North America Oncolytic Virus Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Oncolytic Virus Sales Market Share by Countries (2015-2020)
Figure 48. North America Oncolytic Virus Sales Market Share by Countries in 2018
Figure 49. North America Oncolytic Virus Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Oncolytic Virus Revenue Market Share by Countries in 2018
Figure 51. United States Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Canada Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Mexico Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Europe Oncolytic Virus Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Oncolytic Virus Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Oncolytic Virus Revenue Market Share by Countries in 2019
Figure 57. Germany Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 58. UK Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 59. France Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Russia Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Italy Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Asia-Pacific Oncolytic Virus Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Oncolytic Virus Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Oncolytic Virus Revenue Market Share by Regions 2019
Figure 65. China Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Japan Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Korea Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 68. India Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Southeast Asia Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 70. South America Oncolytic Virus Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Oncolytic Virus Sales Market Share by Countries in 2019
Figure 72. South America Oncolytic Virus Revenue Market Share by Countries in 2019
Figure 73. Brazil Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Argentina Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Middle East and Africa Oncolytic Virus Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Oncolytic Virus Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Oncolytic Virus Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Oncolytic Virus Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Egypt Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Turkey Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 82. South Africa Oncolytic Virus Sales and Growth Rate (2015-2020) (K MT)
Figure 83. Global Oncolytic Virus Sales and Growth Rate (2021-2025) (K MT)
Figure 84. Global Oncolytic Virus Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Oncolytic Virus Market Forecast (2021-2025) (K MT)
Figure 86. Europe Sales Oncolytic Virus Market Forecast (2021-2025) (K MT)
Figure 87. Asia-Pacific Sales Oncolytic Virus Market Forecast (2021-2025) (K MT)
Figure 88. South America Sales Oncolytic Virus Market Forecast (2021-2025) (K MT)
Figure 89. Middle East & Africa Sales Oncolytic Virus Market Forecast (2021-2025) (K MT)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
C型肝炎ウイルスエンベロープタンパク質E2の世界市場 2020年 Market Overview The global Hepatitis C Virus Envelope Protein E2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatit…- 呼吸器合胞体ウイルス付着糖タンパク質の世界市場 2020年 Market Overview The global Respiratory Syncytial Virus Attachment Glycoprotein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…
- エプスタインバーウイルス（HHV-4）感染症治療の世界市場 2020年 Market Overview The global Epstein-Barr Virus (HHV-4) Infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…
- A型肝炎ウイルス細胞受容体2の世界市場 2020年 Market Overview The global Hepatitis A Virus Cellular Receptor 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatit…
- 肝炎ウイルス診断テストの世界市場 2020年 Market Overview The global Hepatitis Viruses Diagnostic Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis …